Literature DB >> 30405757

A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.

Yumei Xu1,2, Zhiying Shao3, Tianyou Tang1, Guihong Liu1, Yuanhu Yao1, Jianshe Wang1, Longzhen Zhang1.   

Abstract

The objective of the present study was to investigate the association between thyroid gland-dosimetric parameters and hypothyroidism induced by intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma (NPC). A total of 52 patients with NPC treated in the Department of Radiation Oncology of The Affiliated Hospital of Xuzhou Medical University, from May 2008 to December 2016 were retrospectively enrolled in the present study and divided into two groups based on thyroid function: The euthyroid and hypothyroid groups. The association between hypothyroidism and clinical or dosimetric parameters were analyzed. Females had a significantly increased probability of suffering from radiation-induced hypothyroidism (RIHT), compared with males (P=0.010). The occurrence of RIHT was significantly negatively associated with thyroid volume prior to radiotherapy (P=0.048). Furthermore, the mean dose (Dmean) and V50 in the hypothyroidism group were significantly increased, compared with the euthyroidism group (P=0.017 and P=0.023, respectively). During the treatment optimization period, dose constraints associated with the thyroid gland demonstrated a significantly protective effect on thyroid function compared with the unconstrained group (P=0.034). According to the receiver operating characteristic curves, the threshold value was 5,160 cGy for Dmean and 54.5% for V50. The 3-year cumulative incidence of RIHT was 67.8% when the Dmean value was >5,160 cGy and 44.6% when the Dmean was <5,160 cGy (log rank test, P=0.036). Furthermore, the 3-year cumulative incidence was 66.1% when the V50 was >54.5%, and 29.9% when the V50 was <54.5% (log rank test, P=0.025). In conclusion, RIHT is associated with radiation dose, particularly with Dmean and V50 of the thyroid gland. Dose constraints associated with the thyroid gland significantly reduced the incidence of hypothyroidism compared with the unconstrained group.

Entities:  

Keywords:  dose threshold; dose-volume parameters; hypothyroidism; intensity-modulated radiotherapy; nasopharyngeal carcinoma

Year:  2018        PMID: 30405757      PMCID: PMC6202536          DOI: 10.3892/ol.2018.9332

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer.

Authors:  Roger Tell; Göran Lundell; Bo Nilsson; Helena Sjödin; Freddi Lewin; Rolf Lewensohn
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-10-01       Impact factor: 7.038

2.  Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma.

Authors:  Shuang Huang; Xiaosheng Wang; Chaosu Hu; Hongmei Ying
Journal:  Med Oncol       Date:  2013-09-03       Impact factor: 3.064

3.  Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma.

Authors:  G Mercado; D J Adelstein; J P Saxton; M Secic; M A Larto; P Lavertu
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

4.  A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma.

Authors:  Zhixiong Lin; Vincent Wing-Cheung Wu; Jing Lin; Huiting Feng; Longhua Chen
Journal:  Thyroid       Date:  2010-11-08       Impact factor: 6.568

5.  Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck.

Authors:  A D Colevas; R Read; J Thornhill; S Adak; R Tishler; P Busse; Y Li; M Posner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-11-01       Impact factor: 7.038

Review 6.  Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review.

Authors:  Marjolein J Boomsma; Hendrik P Bijl; Johannes A Langendijk
Journal:  Radiother Oncol       Date:  2011-04-01       Impact factor: 6.280

7.  A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model.

Authors:  Marjolein J Boomsma; Hendrik P Bijl; Miranda E M C Christianen; Ivo Beetz; Olga Chouvalova; Roel J H M Steenbakkers; Bernard F A M van der Laan; Bruce H R Wolffenbuttel; Sjoukje F Oosting; Cornelis Schilstra; Johannes A Langendijk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-06-19       Impact factor: 7.038

8.  Complications associated with therapeutic neck radiation.

Authors:  M August; J Wang; D Plante; C C Wang
Journal:  J Oral Maxillofac Surg       Date:  1996-12       Impact factor: 1.895

9.  Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.

Authors:  Roberto Diaz; Jerry J Jaboin; Manuel Morales-Paliza; Elizabeth Koehler; John G Phillips; Scott Stinson; Jill Gilbert; Christine H Chung; Barbara A Murphy; Wendell G Yarbrough; Patrick B Murphy; Yu Shyr; Anthony J Cmelak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-04       Impact factor: 7.038

10.  Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma.

Authors:  Yun-Ming Tian; Wei-Wei Xiao; Li Bai; Xue-Wen Liu; Chong Zhao; Tai-Xiang Lu; Fei Han
Journal:  Chin J Cancer       Date:  2015-06-10
View more
  5 in total

1.  A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Authors:  Liang Peng; Yan-Ping Mao; Cheng-Long Huang; Rui Guo; Jun Ma; Wei-Ping Wen; Ling-Long Tang
Journal:  Front Oncol       Date:  2020-09-25       Impact factor: 6.244

2.  Dose-volume derived nomogram as a reliable predictor of radiotherapy-induced hypothyroidism in head and neck cancer patients.

Authors:  Marin Prpic; Ivan Kruljac; Davor Kust; Petar Suton; Neva Purgar; Lora Kirigin Bilos; Marin Gregov; Iva Mrcela; Maja Franceschi; Nikola Djakovic; Ana Frobe
Journal:  Radiol Oncol       Date:  2019-11-20       Impact factor: 2.991

3.  Multivariate NTCP Model of Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma.

Authors:  Guanzhu Shen; Yinglin Peng; Jian Li; Haijun Wu; Guangshun Zhang; Chong Zhao; Xiaowu Deng
Journal:  Front Oncol       Date:  2021-08-23       Impact factor: 6.244

Review 4.  Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.

Authors:  James C H Chow; Ka-Man Cheung; Gavin T C Cheung; Anthony H P Tam; Jeffrey C F Lui; Francis K H Lee; Kwok-Hung Au; Wai-Tong Ng; Anne W M Lee; Harry H Y Yiu
Journal:  Clin Transl Radiat Oncol       Date:  2022-01-24

5.  Thyroid V50 is a risk factor for hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: a retrospective study.

Authors:  Ling Zhou; Jia Chen; Wei Shen; Zheng-Lu Chen; Shuang Huang; Chang-Juan Tao; Ming Chen; Zhong-Hua Yu; Yuan-Yuan Chen
Journal:  Radiat Oncol       Date:  2020-03-23       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.